Name | REMEDIUM, OOO |
---|
INN | 8603130893 |
---|
KPP | 860301001 |
---|
OGRN | 1068603033212 |
---|
OKPO | 34444671 |
---|
Address | 628616, avtonomnyy okrug Khanty-mansiyskiy Avtonomnyy Okrug - Yugra, g. Nizhnevartovsk, ul. Mira, d. D.16 |
|
OKVED code | Type | Name of activity type |
---|
47.73 | Core activity | Retailing drugs in specialized stores (pharmacies) | 02.30.13 | Additional activity | Collecting and harvesting of wild nuts |
Registration date | 21.03.2006 |
---|
Registering department | Mezhrayonnaya inspektsiya Federal'noy nalogovoy sluzhby N 6 po Khanty-Mansiyskomu avtonomnomu okrugu - Yugre |
---|
|
REMEDIUM, OOO (Khanty–Mansi Autonomous Okrug; INN 8603130893) was registered on 21 Mar 2006. The company's authorized capital as of July 1, 2012 was 110000 rub. Type of ownership of REMEDIUM, OOO - Limited liability companies. Form of ownership of REMEDIUM, OOO - Private property. Principal activities of REMEDIUM, OOO: retailing drugs in specialized stores (pharmacies) (47.73), collecting and harvesting of wild nuts (02.30.13). |
Economic indicators2023
Net profit (RAS) of REMEDIUM, OOO made up 2.00 thousand RUB over 2023 compared to net loss of 6.08 million RUB over 2022, the company informed. Revenue decreased in the accounting period by 41.21% to 38.99 million RUB from 66.33 million RUB in 2022. 2022
Net loss (RAS) of REMEDIUM, OOO increased by 18.07% to 6.08 million RUB from 5.15 million RUB over 2021, the company informed. Revenue decreased in the accounting period by 21.68% to 66.33 million RUB from 84.69 million RUB in 2021; cost of goods sold decreased by 21.59% to 46.32 million RUB from 59.08 million RUB; sales loss grew 3.04 times to 3.43 million RUB from 1.13 million RUB. 2021
Net loss (RAS) of REMEDIUM, OOO increased 1.51 times to 5.15 million RUB from 3.41 million RUB over 2020, the company informed. Revenue decreased in the accounting period by 18.31% to 84.69 million RUB from 103.68 million RUB in 2020; cost of goods sold decreased by 21.34% to 59.08 million RUB from 75.11 million RUB; sales loss made up 1.13 million RUB compared to sales profit of 231.00 thousand RUB. 2020
Net loss (RAS) of REMEDIUM, OOO dropped over 2020 2.60 times to 3.41 million RUB from 8.86 million RUB KAgent.Entities.Balance, the company informed. Revenue decreased in the accounting period by 17.90% to 103.68 million RUB from 126.28 million RUB in 2019; cost of goods sold decreased by 22.22% to 75.11 million RUB from 96.56 million RUB; sales profit made up 231.00 thousand RUB compared to sales loss of 1.71 million RUB. 2018
Net loss (RAS) of REMEDIUM, OOO increased 2.30 times to 8.07 million RUB from 3.51 million RUB over 2017, the company informed. Revenue decreased in the accounting period by 8.77% to 125.91 million RUB from 138.01 million RUB in 2017; cost of goods sold decreased by 7.10% to 97.90 million RUB from 105.38 million RUB; sales loss made up 3.83 million RUB compared to sales profit of 1.52 million RUB. 2017
Net loss (RAS) of REMEDIUM, OOO increased 5.89 times to 3.51 million RUB from 596.00 thousand RUB over 2016, the company informed. Revenue decreased in the accounting period by 13.62% to 138.01 million RUB from 159.76 million RUB in 2016; cost of goods sold decreased by 16.09% to 105.38 million RUB from 125.59 million RUB; sales profit fell by 22.14% to 1.52 million RUB from 1.96 million RUB. 2016
Net loss (RA) of REMEDIUM, OOO made up 596.00 thousand RUB over 2016 compared to net profit of 8.89 million RUB over 2015, the company informed. Revenue decreased in the accounting period by 13.33% to 159.76 million RUB from 184.33 million RUB in 2015; cost of goods sold decreased by 8.01% to 125.59 million RUB from 136.53 million RUB; sales profit fell 6.26 times to 1.96 million RUB from 12.24 million RUB. 2014
Net profit (RAS) of REMEDIUM, OOO grew over 2014 2.31 times to 5.89 million RUB from 2.55 million RUB over 2013, the company informed. Revenue increased in the accounting period by 19.32% to 114.27 million RUB from 95.77 million RUB over 2013; cost of goods sold grew by 15.64% to 84.01 million RUB from 72.65 million RUB; sales profit went up 1.85 times to 8.17 million RUB from 4.42 million RUB. 2013
Net profit (RAS) of REMEDIUM, OOO dropped in 2013 by 16.88% to 2.55 million RUB from 3.07 million RUB over the same period in 2012, the company informed. Revenue increased in the accounting period by 6.55% to 95.77 million RUB from 89.89 million RUB over 2012; cost of goods sold grew by 8.24% to 72.65 million RUB from 67.12 million RUB; sales profit fell by 3.20% to 4.42 million RUB from 4.57 million RUB. 2012
Net profit (RAS) of REMEDIUM, OOO dropped in 2012 by 24.84% to 3.07 million RUB from 4.08 million RUB over the same period in 2011, the company informed. Revenue increased in the accounting period by 6.39% to 89.89 million RUB from 84.48 million RUB over 2011; cost of goods sold grew by 6.98% to 85.32 million RUB from 79.75 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|